ERBB2 and breast cancer: Regarding the molecular classification of breast cancer, samples from this study mainly corresponded to luminal group A, which have a high expression of oestrogen receptors and low levels of proliferation, resulting in low mitotic tumour cells and excellent prognosis [39], followed by luminal B tumours, triple negative, and HER2.